Inventor
Georgette Castanedo
Inventor
Redwood City, CA, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes24%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
PatentTitleYear
9,943,519Pharmaceutical compounds20189,790,183'Pyridyl inhibitors of hedgehog signalling'20179,605,005'Alkynyl alcohols and methods of use'20179,487,533'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20169,321,761'Pyridyl inhibitors of hedgehog signalling'20169,278,961'Pyridyl inhibitors of hedgehog signalling'20169,034,866'Tricyclic compounds and methods of use therefor'20158,993,563'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20158,802,670'Pharmaceutical compounds'20148,563,540'Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use'20138,450,315'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20138,445,487'Purine PI3K inhibitor compounds and methods of use'20138,440,651'Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use'20138,394,796'Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use'20138,383,620'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20138,173,650'Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use'20128,158,625'Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use'20128,158,624'Purine PI3K inhibitor compounds and methods of use'20128,158,626'Thiazolopyrimidine PI3K inhibitor compounds and methods of use'20127,893,059'Thiazolopyrimidine PI3K inhibitor compounds and methods of use'20117,888,364'Pyridyl inhibitors of hedgehog signalling'20117,888,352'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20117,846,929'Phosphoinositide 3-kinase inhibitor compounds and methods of use'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2018Patents assigned to GENENTECH INC (22)· patent assignee history
2010–2017Based in Redwood City, CA, US· patent location history
2011–2018Patents assigned to HOFFMANN LA ROCHE (8)· patent assignee history
2012–2016Patents assigned to SUTHERLIN DANIEL P (11)· patent assignee history
2012–2016Patents assigned to CASTANEDO GEORGETTE (10)· patent assignee history
2012–2016Patents assigned to FOLKES Adrian (7)· patent assignee history
2012–2018Based in South San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 22 | 2010–2018 |
| SUTHERLIN DANIEL P | 11 | 2012–2016 |
| CASTANEDO GEORGETTEself | 10 | 2012–2016 |
| HOFFMANN LA ROCHE | 8 | 2011–2018 |
| FOLKES Adrian | 7 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Redwood City, California, US | 17 | 2010–2017 |
| South San Francisco, California, US | 6 | 2012–2018 |